SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels
Harvey W Kaufman, Justin K Niles, Martin H Kroll, Caixia Bi, Michael F Holick
PLOS ONE, doi:10.1371/journal.pone.0239252
Until treatment and vaccine for coronavirus disease-2019 (COVID-19) becomes widely available, other methods of reducing infection rates should be explored. This study used a retrospective, observational analysis of deidentified tests performed at a national clinical laboratory to determine if circulating 25-hydroxyvitamin D (25(OH)D) levels are associated with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) positivity rates. Over 190,000 patients from all 50 states with SARS-CoV-2 results performed mid-March through mid-June, 2020 and matching 25(OH)D results from the preceding 12 months were included. Residential zip code data was required to match with US Census data and perform analyses of race/ethnicity proportions and latitude. A total of 191,779 patients were included (median age, 54 years [interquartile range 40.4-64.7]; 68% female. The SARS-CoV-2 positivity rate was 9.3% (95% C.I. 9.2-9.5%) and the mean seasonally adjusted 25(OH)D was 31.7 (SD 11.7). The SARS-CoV-2 positivity rate was higher in the 39,190 patients with "deficient" 25(OH)D values (<20 ng/mL) (12.5%, 95% C.I. 12.2-12.8%) than in the 27,870 patients with "adequate" values (30-34 ng/mL) (8.1%, 95% C.I. 7.8-8.4%) and the 12,321 patients with values �55 ng/mL (5.9%, 95% C.I. 5.5-6.4%). The association between 25 (OH)D levels and SARS-CoV-2 positivity was best fitted by the weighted second-order polynomial regression, which indicated strong correlation in the total population (R 2 = 0.96) and in analyses stratified by all studied demographic factors. The association between lower SARS-CoV-2 positivity rates and higher circulating 25(OH)D levels remained significant in a multivariable logistic model adjusting for all included demographic factors (adjusted odds ratio 0.984 per ng/mL increment, 95% C.I. 0.983-0.986; p<0.001). SARS-CoV-2 positivity is strongly and inversely associated with circulating 25(OH)D levels, a relationship that persists across latitudes, races/ethnicities, both sexes, and age ranges. Our findings provide impetus to explore the role of vitamin D supplementation in reducing the risk for SARS-CoV-2 infection and COVID-19 disease.
Author Contributions Conceptualization: Harvey W. Kaufman, Justin K. Niles, Martin H. Kroll
References
Berry, Hesketh, Power, Hypponen, Vitamin D status has a linear association with seasonal infections and lung function in British adults, The British Journal of Nutrition,
doi:10.1017/S0007114511001991D'avolio, Avataneo, Manca, 25-Hydroxyvitamin D Concentrations are Lower in Patients with Positive PCR for SARS-CoV-2, Nutrients,
doi:10.3390/nu12051359Grant, Lahore, Mcdonnell, Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients
Holick, Binkley, Bischoff-Ferrari, Evaluation, Treatment & Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab,
doi:10.1210/jc.2011-0385Ingham, Jones, Camargo, Study, G. Association of vitamin D deficiency with severity of acute respiratory infection: A case-control study in New Zealand children, European Respiratory Journal
Martineau, Jolliffe, Hooper, Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ,
doi:10.1136/bmj.i6583Rhodes, Dunstan, Laird, COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D, BMJ Nutrition, Prevention & Health,
doi:10.1136/bmjnph-2020-000110Sabetta, Depetrillo, Cipriani, Smardin, Burns et al., Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults, PLoS One,
doi:10.1371/journal.pone.0011088Zdrenghea, Makrinioti, Bagacean, Bush, Johnston et al., Vitamin D modulation of innate immune responses to respiratory viral infections, Rev Med Virol,
doi:10.1002/rmv.1909DOI record:
{
"DOI": "10.1371/journal.pone.0239252",
"ISSN": [
"1932-6203"
],
"URL": "http://dx.doi.org/10.1371/journal.pone.0239252",
"author": [
{
"affiliation": [],
"family": "Kaufman",
"given": "Harvey W.",
"sequence": "first"
},
{
"affiliation": [],
"family": "Niles",
"given": "Justin K.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Kroll",
"given": "Martin H.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bi",
"given": "Caixia",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-6023-9062",
"affiliation": [],
"authenticated-orcid": true,
"family": "Holick",
"given": "Michael F.",
"sequence": "additional"
}
],
"container-title": "PLOS ONE",
"container-title-short": "PLoS ONE",
"content-domain": {
"crossmark-restriction": false,
"domain": [
"www.plosone.org"
]
},
"created": {
"date-parts": [
[
2020,
9,
17
]
],
"date-time": "2020-09-17T17:48:03Z",
"timestamp": 1600364883000
},
"deposited": {
"date-parts": [
[
2020,
9,
17
]
],
"date-time": "2020-09-17T17:48:28Z",
"timestamp": 1600364908000
},
"editor": [
{
"affiliation": [],
"family": "Reddy",
"given": "Sakamuri V.",
"sequence": "first"
}
],
"indexed": {
"date-parts": [
[
2024,
4,
2
]
],
"date-time": "2024-04-02T15:10:56Z",
"timestamp": 1712070656293
},
"is-referenced-by-count": 281,
"issue": "9",
"issued": {
"date-parts": [
[
2020,
9,
17
]
]
},
"journal-issue": {
"issue": "9",
"published-online": {
"date-parts": [
[
2020,
9,
17
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
9,
17
]
],
"date-time": "2020-09-17T00:00:00Z",
"timestamp": 1600300800000
}
}
],
"link": [
{
"URL": "https://dx.plos.org/10.1371/journal.pone.0239252",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "340",
"original-title": [],
"page": "e0239252",
"prefix": "10.1371",
"published": {
"date-parts": [
[
2020,
9,
17
]
]
},
"published-online": {
"date-parts": [
[
2020,
9,
17
]
]
},
"publisher": "Public Library of Science (PLoS)",
"reference": [
{
"article-title": "COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D",
"author": "J Rhodes",
"first-page": "bmjnph-2020",
"journal-title": "BMJ Nutrition, Prevention & Health",
"key": "pone.0239252.ref001",
"year": "2020"
},
{
"DOI": "10.1136/bmjnph-2020-000096",
"article-title": "Avoidance of vitamin D deficiency to slow the COVID-19 pandemic",
"author": "M. Kohlmeier",
"doi-asserted-by": "crossref",
"journal-title": "BMJ Nutrition, Prevention & Health",
"key": "pone.0239252.ref002",
"volume": "3",
"year": "2020"
},
{
"DOI": "10.1002/rmv.1909",
"article-title": "Vitamin D modulation of innate immune responses to respiratory viral infections",
"author": "MT Zdrenghea",
"doi-asserted-by": "crossref",
"first-page": "e1909",
"journal-title": "Rev Med Virol",
"key": "pone.0239252.ref003",
"volume": "27",
"year": "2017"
},
{
"DOI": "10.1016/S0140-6736(20)30628-0",
"article-title": "COVID-19: consider cytokine storm syndromes and immunosuppression",
"author": "P Mehta",
"doi-asserted-by": "crossref",
"first-page": "1033",
"issue": "10229",
"journal-title": "Lancet",
"key": "pone.0239252.ref004",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.3390/nu12040988",
"article-title": "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths",
"author": "WB Grant",
"doi-asserted-by": "crossref",
"first-page": "988",
"issue": "4",
"journal-title": "Nutrients",
"key": "pone.0239252.ref005",
"volume": "12",
"year": "2020"
},
{
"article-title": "25-Hydroxyvitamin D Concentrations are Lower in Patients with Positive PCR for SARS-CoV-2",
"author": "A D’Avolio",
"first-page": "1359",
"issue": "5",
"journal-title": "Nutrients. 2020",
"key": "pone.0239252.ref006",
"volume": "12"
},
{
"DOI": "10.1016/j.dsx.2020.04.050",
"article-title": "Vitamin D concentrations and COVID-19 infection in UK Biobank",
"author": "CE Hastie",
"doi-asserted-by": "crossref",
"first-page": "561",
"issue": "4",
"journal-title": "Diabetes Metab Syndr",
"key": "pone.0239252.ref007",
"volume": "14",
"year": "2020"
},
{
"key": "pone.0239252.ref008",
"unstructured": "United States Food and Drug Administration. Quest SARS-CoV-2 rRT-PCR (Quest Diagnostics Infectious Disease, Inc.)–Manufacturer Instructions/Package Insert. https://www.fda.gov/media/136231/download. Accessed August 20, 2020."
},
{
"key": "pone.0239252.ref009",
"unstructured": "United States Food and Drug Administration. cobas SARS-CoV-2 (Roche Molecular Systems, Inc.)–Manufacturer Instructions/Package. https://www.fda.gov/media/136049/download. Accessed August 20, 2020."
},
{
"key": "pone.0239252.ref010",
"unstructured": "United States Food and Drug Administration. Panther Fusion SARS-CoV-2 Assay (Hologic, Inc.)–Manufacturer Instructions/Package. https://www.fda.gov/media/136156/download. Accessed August 20, 2020."
},
{
"key": "pone.0239252.ref011",
"unstructured": "United States Food and Drug Administration. Aptima SARS-CoV-2 assay–Instructions for Use. https://www.fda.gov/media/138096/download. Accessed August 20, 2020."
},
{
"key": "pone.0239252.ref012",
"unstructured": "U.S. Census Bureau; American Community Survey, 2018 American Community Survey 5-Year Estimates, Table B03002; generated by Justin Niles; using data.census.gov; Available from: https://data.census.gov/cedsi/; (1 June 2020)"
},
{
"article-title": "Temporal Relationship between Vitamin D Status and Parathyroid Hormone in the United States",
"author": "MH Kroll",
"journal-title": "PloS ONE",
"key": "pone.0239252.ref013",
"year": "2015"
},
{
"DOI": "10.2174/18715281113129990046",
"article-title": "The role of vitamin D in prevention and treatment of infection",
"author": "CF Gunville",
"doi-asserted-by": "crossref",
"first-page": "239",
"issue": "4",
"journal-title": "Inflamm Allergy Drug Targets",
"key": "pone.0239252.ref014",
"volume": "12",
"year": "2013"
},
{
"article-title": "The Whiti Te Ra Study, G. Association of vitamin D deficiency with severity of acute respiratory infection: A case-control study in New Zealand children",
"author": "TR Ingham",
"first-page": "439",
"journal-title": "European Respiratory Journal",
"key": "pone.0239252.ref015",
"volume": "44",
"year": "2014"
},
{
"DOI": "10.1371/journal.pone.0011088",
"article-title": "Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults",
"author": "JR Sabetta",
"doi-asserted-by": "crossref",
"first-page": "e11088",
"journal-title": "PLoS One",
"key": "pone.0239252.ref016",
"volume": "5",
"year": "2010"
},
{
"DOI": "10.1136/bmj.i6583",
"article-title": "Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta‐analysis of individual participant data",
"author": "AR Martineau",
"doi-asserted-by": "crossref",
"first-page": "i6583",
"journal-title": "BMJ",
"key": "pone.0239252.ref017",
"volume": "356",
"year": "2017"
},
{
"DOI": "10.1017/S0007114511001991",
"article-title": "Vitamin D status has a linear association with seasonal infections and lung function in British adults",
"author": "DJ Berry",
"doi-asserted-by": "crossref",
"first-page": "1433",
"issue": "9",
"journal-title": "The British Journal of Nutrition",
"key": "pone.0239252.ref018",
"volume": "106",
"year": "2011"
},
{
"DOI": "10.1111/apt.15752",
"article-title": "Letter: Covid-19, and vitamin D",
"author": "A Panarese",
"doi-asserted-by": "crossref",
"first-page": "993",
"issue": "10",
"journal-title": "Aliment Pharmacol Ther",
"key": "pone.0239252.ref019",
"volume": "51",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)31102-8",
"article-title": "Sharpening the global focus on ethnicity and race in the tie of COVID-19",
"author": "N Bhala",
"doi-asserted-by": "crossref",
"first-page": "1673",
"issue": "10238",
"journal-title": "Lancet",
"key": "pone.0239252.ref020",
"volume": "395",
"year": "2020"
},
{
"key": "pone.0239252.ref021",
"unstructured": "Centers for Disease Control and Prevention. COVID-19 in Racial and Ethnic Minority Groups. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/racial-ethnic-minorities.html#10. Accessed June 4, 2020."
},
{
"DOI": "10.1001/jama.2020.6548",
"article-title": "COVID-19 and African Americans",
"author": "CW Yancy",
"doi-asserted-by": "crossref",
"first-page": "1891",
"issue": "19",
"journal-title": "JAMA",
"key": "pone.0239252.ref022",
"volume": "323",
"year": "2020"
},
{
"DOI": "10.1210/jc.2011-0385",
"article-title": "Evaluation, Treatment & Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline",
"author": "MF Holick",
"doi-asserted-by": "crossref",
"first-page": "1911",
"issue": "7",
"journal-title": "J Clin Endocrinol Metab",
"key": "pone.0239252.ref023",
"volume": "96",
"year": "2011"
}
],
"reference-count": 23,
"references-count": 23,
"relation": {},
"resource": {
"primary": {
"URL": "https://dx.plos.org/10.1371/journal.pone.0239252"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"Multidisciplinary"
],
"subtitle": [],
"title": "SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1371/journal.pone.corrections_policy",
"volume": "15"
}
